Literature DB >> 15156179

Core-binding factors in hematopoiesis and immune function.

Marella F T R de Bruijn1, Nancy A Speck.   

Abstract

Core binding factors are heterodimeric transcription factors containing a DNA binding Runx1, Runx2, or Runx3 subunit, along with a non DNA binding CBF beta subunit. All four subunits are required at one or more stages of hematopoiesis. This review describes the role of Runx1 and CBF beta in the initiation of hematopoiesis in the embryo, and in the emergence of hematopoietic stem cells. We also discuss the later stages of hematopoiesis for which members of the core binding factor family are required, as well as the recently described roles for these proteins in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15156179     DOI: 10.1038/sj.onc.1207763

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  94 in total

1.  T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.

Authors:  Wenyan Zhang; Juan Du; Sean L Evans; Yunkai Yu; Xiao-Fang Yu
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 2.  Architectural epigenetics: mitotic retention of mammalian transcriptional regulatory information.

Authors:  Sayyed K Zaidi; Daniel W Young; Martin Montecino; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Mol Cell Biol       Date:  2010-08-09       Impact factor: 4.272

3.  HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.

Authors:  Judd F Hultquist; Rebecca M McDougle; Brett D Anderson; Reuben S Harris
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-13       Impact factor: 2.205

Review 4.  The RUNX complex: reaching beyond haematopoiesis into immunity.

Authors:  Dominic Chih-Cheng Voon; Yit Teng Hor; Yoshiaki Ito
Journal:  Immunology       Date:  2015-10-25       Impact factor: 7.397

5.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

6.  Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.

Authors:  Gauthami Jalagadugula; Guangfen Mao; Gurpreet Kaur; Lawrence E Goldfinger; Danny N Dhanasekaran; A Koneti Rao
Journal:  Blood       Date:  2010-09-27       Impact factor: 22.113

7.  Differential chromatin looping regulates CD4 expression in immature thymocytes.

Authors:  Huimin Jiang; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

8.  A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis.

Authors:  Oren Ben-Ami; Niv Pencovich; Joseph Lotem; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

9.  A proximal activator of transcription in epithelial-mesenchymal transition.

Authors:  Christo D Venkov; Andrew J Link; Jennifer L Jennings; David Plieth; Tsutomu Inoue; Kojiro Nagai; Carol Xu; Yoana N Dimitrova; Frank J Rauscher; Eric G Neilson
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

10.  Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3.

Authors:  Merav Yarmus; Eilon Woolf; Yael Bernstein; Ofer Fainaru; Varda Negreanu; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.